Top Technologies in Health and Wellness, 2017

Top Technologies in Health and Wellness, 2017

Top technology trends that are likely to have an impact in 2017

RELEASE DATE
28-Apr-2017
REGION
Global
Deliverable Type
Technology Research
Research Code: D7C9-01-00-00-00
SKU: HC02820-GL-TR_20220
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02820-GL-TR_20220

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This strategic research service, Health & Wellness Top 10 Technologies, depicts the current landscape and the new trends in a series of developments associated with innovations in Precision Oncology, Biobetters,Human Microbiomics, Immune Engineering, Cancer/Tumor Profiling, Cellular Therapeutics, Tissue Engineering, Molecular Diagnostics, Gene Editing and Predictive Biomarkers.

Techvision's professionals have monitored, gathered, and analyzed numerous emerging and disruptive technologies selecting this top 10 technologies, by contacting an extensive network of innovators, technology developers, financial institutions, technologists and researchers, among other players in the ecosystem, with the aim to provide your company or institution with a notable intelligence work that can help you build and implement strong growth strategies by leverage disruptive technologies and emerging innovations.

Table of Contents

1.1 Research Scope and Index

1.2 Selection Methodology

1.3 Assessment of Top Technologies: 2015 and 2016

1.4 Global Health & Wellness Trends Across 2017

1.5 Key Findings

1.5 Key Findings (continued)

2.1 Precision Medicine Advances Likely to Disrupt Existing Cancer Management Landscape in the Future

2.2 Big Pharma Likely to Lead Global Precision Oncology Innovations

2.3 Precision Oncology Likely to Witness Continued Growth in IP and Funding Activities

2.4 Precision Medicine Innovations Likely to Transform Global Cancer Management Landscape

3.1 Next-generation Sequencing Technologies Likely to Disrupt Existing Molecular Diagnostic Platforms

3.2 Emerging Molecular Diagnostic Platforms Present a Growing Market Opportunity

3.3 US Leads the Patent and Funding Landscape for MDx Innovations

3.4 Emerging NGS Platforms Likely to Transform Global MDx Landscape

4.1 Predictive Biomarker Technologies Lead Personalized Medicine Platforms

4.2 US Leads the IP Landscape for Predictive Biomarkers

4.3 Personalized Genomics Start-ups Lead the Venture Landscape

4.4 Genomic Tests Likely to Lead Biomarker Enabling Platforms

5.1 Liquid Biopsy Profiling Platforms Likely to Disrupt Tumor Tissue Biopsy Techniques

5.2 Tumor Profiling Market Poised for Continued Growth

5.3 US Leads the IP Landscape for Tumor Profiling

5.4 Liquid Biopsy Startups Dominate the Venture Landscape

5.5 Liquid Biopsy Techniques likely to Transform Early Tumor Screening

6.1 Stem Cell Therapy is Expected to Address the Most Crucial Medical Challenges

6.2 The Stem Cell Therapy Field is Very Active In Terms Of New Companies Significantly Impacting the Market by 2021

6.3 Stem Cells Paving the Way for Precision Medicine Through an Unprecedented Technology Synergy

6.4 New Japanese Regulatory Framework Impacting Healthcare Globally

7.1 Gene Editing Techniques Paving the way for Disease Research and Novel Therapeutics

7.2 CRISPR-Cas9 Gene Editing Technology Will Significantly Impact the Market by 2021

7.3 Gene Editing Techniques Paving the Way for Precision Medicine

7.4 North America and Europe are Dominating the Gene Editing Market

8.1 Microbiomics Impacts Key Consumer Benefit Areas Such as Skin and Gut Health

8.2 Diversity of Market Potential Provides Multiple Opportunities for Rapid Growth

8.3 US-based Inventors are Leading in Microbiome-Focused R&D

8.4 Skincare, GI, and Immunity are Key Consumer Benefit Areas for Microbiome-Focused Products

9.1 Immunotherapy Is Pushing the Barriers of Standard Cancer Therapy

9.2 Replacing Chemotherapy as First-line Treatment Option Increases Revenue Potential of Immunotherapies

9.3 US-Based Inventors are Leading In Immune-Focused R&D

9.4 Immuno-oncology Is the Largest Application Segment Present Under Immunotherapy

10.1 Biobetters: A Whole New Generation of Biosimilars

10.2 Greater Adoption of Biosimilars Directly Impact by the Degree of Pharmaceutical Involvement

10.3 Patenting across Biosimilars Largely Happens around Process and Production Techniques

10.4 Oncology is Currently the Disease Area Getting Impacted the Most by Biosimilars

11.1 Tissue Engineering Has Become a Promising Field among the Foremost Innovative Areas of Medical Care Today

11.2 3D Bioprinting Technology is Expected to Have Greatest Impact in the Market by 2025

11.3 Additional Commercial Opportunities in Assembly, Manufacturing, and Drug Delivery Sectors

11.4 Regional Differentiation Approaches Make the Tissue Engineering Sphere Highly Dynamic

Legal Disclaimer

12.1 The Frost & Sullivan Story

12.2 Value Proposition: Future of Your Company & Career

12.3 Global Perspective

12.4 Industry Convergence

12.5 360º Research Perspective

12.6 Implementation Excellence

12.7 Our Blue Ocean Strategy

This strategic research service, Health & Wellness Top 10 Technologies, depicts the current landscape and the new trends in a series of developments associated with innovations in Precision Oncology, Biobetters,Human Microbiomics, Immune Engineering, Cancer/Tumor Profiling, Cellular Therapeutics, Tissue Engineering, Molecular Diagnostics, Gene Editing and Predictive Biomarkers. Techvision's professionals have monitored, gathered, and analyzed numerous emerging and disruptive technologies selecting this top 10 technologies, by contacting an extensive network of innovators, technology developers, financial institutions, technologists and researchers, among other players in the ecosystem, with the aim to provide your company or institution with a notable intelligence work that can help you build and implement strong growth strategies by leverage disruptive technologies and emerging innovations.
More Information
Deliverable Type Technology Research
No Index No
Podcast No
Author Madhumitha Rangesa
WIP Number D7C9-01-00-00-00
Is Prebook No